AKT1 and neoplasm: Gallic acid exhibits anti-tumor effects on brain gliomas by inhibiting the expression of ADAM17, p-AKT, and p-ERK, thereby suppressing the PI3K/Akt and Ras/MAPK signaling pathways to mitigate tumor cell aggressiveness (51).